# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-20-056552
Filing Date
2020-05-05
Accepted
2020-05-05 08:35:54
Documents
15
Period of Report
2020-05-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2018517d1_8k.htm | 8-K | 18849
2 | EXHIBIT 99.1 | tm2018517d1_ex99-1.htm | EX-99.1 | 8654
3 | EXHIBIT 99.2 | tm2018517d1_ex99-2.htm | EX-99.2 | 12257
4 | GRAPHIC | image_001.gif | GRAPHIC | 2678
5 | GRAPHIC | image_001.jpg | GRAPHIC | 88831
6 | GRAPHIC | image_002.jpg | GRAPHIC | 78665
7 | GRAPHIC | image_003.jpg | GRAPHIC | 84206
8 | GRAPHIC | image_004.jpg | GRAPHIC | 76789
9 | GRAPHIC | image_005.jpg | GRAPHIC | 74771
10 | GRAPHIC | image_006.jpg | GRAPHIC | 81356
11 | GRAPHIC | image_007.jpg | GRAPHIC | 70434
12 | GRAPHIC | image_008.jpg | GRAPHIC | 80759
13 | GRAPHIC | image_009.jpg | GRAPHIC | 79462
14 | GRAPHIC | image_010.jpg | GRAPHIC | 67664
15 | GRAPHIC | image_011.jpg | GRAPHIC | 63179
| Complete submission text file | 0001104659-20-056552.txt |  | 1205867

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 20847049
SIC: 2834 Pharmaceutical Preparations